English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Sunday, September 26, 2021
Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin
研究者公佈有關多格列艾汀糖尿病緩解的重要研究
研究者公布有关多格列艾汀糖尿病缓解的重要研究
Wednesday, September 15, 2021
华领医药与国药控股签署供应链战略合作协议 加速商业化布局
華領醫藥與國藥控股簽署供應鏈戰略合作協議 加速商業化佈局
Hua and Sinopharm Announced Supply Chain Strategic Cooperation
Thursday, August 19, 2021
华领医药公布2021年中期业绩
華領醫藥公佈2021年中期業績
Hua Medicine Announces 2021 Interim Results
Friday, April 23, 2021
华领医药糖尿病首创新药多扎格列艾汀NDA获NMPA受理!为全球首个葡萄糖激酶激活剂

Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575